Antibody engineering promotes nanomedicine for cancer treatment

Nanomedicine (Lond). 2010 Oct;5(8):1141-5. doi: 10.2217/nnm.10.94.
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies, Monoclonal / genetics
  • Antibodies, Monoclonal / therapeutic use*
  • Antibody Affinity
  • Genetic Engineering / methods
  • Humans
  • Mice
  • Nanomedicine / methods*
  • Nanotechnology / methods
  • Neoplasms / immunology*
  • Neoplasms / therapy*
  • Recombinant Fusion Proteins / immunology
  • Recombinant Fusion Proteins / therapeutic use

Substances

  • Antibodies, Monoclonal
  • Recombinant Fusion Proteins